Clinical trial / 2005
Potato glycoalkaloids cleared slowly without acute systemic effects at tested single doses.
An escalating single-dose trial administered oral potato glycoalkaloids as liquid solutions or mashed potatoes to two or three subjects across six dosage levels. None of the treatments provoked acute systemic toxicity. One subject given the highest dose of 1.25 mg/kg body weight developed nausea and emesis roughly four hours later, while elimination usually required more than 24 hours.
- Study type
- Ascending single-dose study
- Who was studied
- Human subjects (2-3 per group across 6 treatments)
- What was measured
- glycoalkaloid toxicity and pharmacokinetics
THE PAPER
Potato glycoalkaloids and adverse effects in humans: an ascending dose study.
Mensinga TT, Sips AJ, Rompelberg CJ, van Twillert K, Meulenbelt J, van den Top HJ, van Egmond HP. Regul Toxicol Pharmacol, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.